Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

CD55 Antikörper (PE)

CD55 Reaktivität: Human, Primate FACS Wirt: Maus Monoclonal MEM-118 PE

Produktnummer ABIN951352

Datenblatt (PDF)

Target Alle CD55 Antikörper anzeigen

CD55 (Complement Decay-Accelerating Factor (CD55))
Reaktivität
125

32

7

4

4

4

3

2

2

2
Human, Primate
Wirt
89

63

6

5

2

1

1
Maus
Passende Sekundärantikörper
Klonalität
102

63

2
Monoklonal
Konjugat
78

16

15

12

5

4

3

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
Dieser CD55 Antikörper ist konjugiert mit PE
Applikation
94

91

44

32

29

26

17

15

14

14

8

4

4

3

3

1

1

1

1
Flow Cytometry (FACS)

Spezifität

This antibody recognizes an epitope in SCR4 domain of CD55 (Decay accelerating factor, DAF), a 60-70 kDa glycosylphosphatidylinositol (GPI)-anchored single chain glycoprotein. CD55 is widely expressed on hematopoietic and on many non-hematopoietic cells, it is weakly present on NK cells.

Kreuzreaktivität (Details)

Species reactivity (tested):Human, Non-Human Primates

Klon

MEM-118

Isotyp

IgM

Top Product

Discover our top product CD55 Primärantikörper
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibody
CD55 Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 1G3 unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 35-285) antibody
CD55 Reaktivität: Human WB, ELISA, IHC (fro), ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 40-300) antibody
CD55 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 51-79) antibody
CD55 Reaktivität: Human FACS, WB, IHC, IF, ELISA Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibody
CD55 Reaktivität: Human WB, IF, ELISA Wirt: Maus Monoclonal 1D7 unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (Center) antibody
CD55 Reaktivität: Human WB, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) antibody
CD55 Reaktivität: Human, Non-Human Primate FACS, WB, IP, IHC (p) Wirt: Maus Monoclonal MEM-118 unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 254-372) antibody
CD55 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 35-126) antibody
CD55 Reaktivität: Human IHC, IF, ELISA Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) antibody (Biotin)
CD55 Reaktivität: Human, Non-Human Primate FACS, WB, IP, IHC (p) Wirt: Maus Monoclonal MEM-118 Biotin

Applikationshinweise

Optimal working dilution should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Buffer

Phosphate buffered saline (PBS) containing 15 mM sodium azide and 0.2 % (w/v) high-grade protease free Bovine Serum Albumin (BSA) as a stabilizing agent

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Target

CD55 (Complement Decay-Accelerating Factor (CD55))

Andere Bezeichnung

CD55 / DAF (CD55 Produkte)

Hintergrund

CD55 (decay-accelerating factor, DAF) is a GPI-anchored membrane glycoprotein that protects autologous cells from classical and alternative pathway of complement cascade. Bidirectional interactions between CD55 and CD97 are involved in T cell regulation and CD55 can still regulate complement when bound to CD97. In tumours, besides protection agains complement, CD55 promotes neoangiogenesis, tumorigenesis, invasiveness and evasion of apoptosis.Synonyms: Complement decay-accelerating factor

Gen-ID

1604

Pathways

Komplementsystem, Regulation of Leukocyte Mediated Immunity